Arkolith/Insider Trading/TRAW/Form 4

Leaman John Harold

DirectorTraws Pharma, Inc. (TRAW) · full profile →Form 4 · filed Dec 16, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2025Grant(A)4K—$04K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 12, 2025Grant(A)16K—$016K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001586657-25-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML